Bitcoin halving
What does that mean?
$2.79T
Total marketcap
$100.68B
Total volume
BTC 49.60%     ETH 15.27%
Dominance

Verona Pharma VRNA Stock

16.09 USD {{ price }} -2.484848% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
1.3B USD
LOW - HIGH [24H]
15.8 - 16.73 USD
VOLUME [24H]
306.78K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.72 USD

Verona Pharma Price Chart

Verona Pharma VRNA Financial and Trading Overview

Verona Pharma stock price 16.09 USD
Previous Close 21.51 USD
Open 21.54 USD
Bid 0 USD x 800
Ask 0 USD x 800
Day's Range 20.72 - 21.54 USD
52 Week Range 3.85 - 26.44 USD
Volume 486.58K USD
Avg. Volume 500.47K USD
Market Cap 1.68B USD
Beta (5Y Monthly) 0.191549
PE Ratio (TTM) N/A
EPS (TTM) -0.72 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 32.43 USD

VRNA Valuation Measures

Enterprise Value 1.44B USD
Trailing P/E N/A
Forward P/E -19.2
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 3664.1082
Price/Book (mrq) 6.029118
Enterprise Value/Revenue 3140.305
Enterprise Value/EBITDA -23.345

Trading Information

Verona Pharma Stock Price History

Beta (5Y Monthly) 0.191549
52-Week Change 404.05%
S&P500 52-Week Change 20.43%
52 Week High 26.44 USD
52 Week Low 3.85 USD
50-Day Moving Average 21.39 USD
200-Day Moving Average 17.6 USD

VRNA Share Statistics

Avg. Volume (3 month) 500.47K USD
Avg. Daily Volume (10-Days) 314.52K USD
Shares Outstanding 79.46M
Float 56.02M
Short Ratio 5.59
% Held by Insiders 3.14%
% Held by Institutions 69.93%
Shares Short 2.65M
Short % of Float N/A
Short % of Shares Outstanding 3.32%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -13589.29%
Gross Margin 24.45%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -15.79%
Return on Equity (ttm) -30.074%

Income Statement

Revenue (ttm) 458K USD
Revenue Per Share (ttm) 0.006 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 112K USD
EBITDA -61609000 USD
Net Income Avi to Common (ttm) -60607000 USD
Diluted EPS (ttm) -0.87
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 291.42M USD
Total Cash Per Share (mrq) 3.67 USD
Total Debt (mrq) 20.52M USD
Total Debt/Equity (mrq) 7.42 USD
Current Ratio (mrq) 11.571
Book Value Per Share (mrq) 3.503

Cash Flow Statement

Operating Cash Flow (ttm) -51132000 USD
Levered Free Cash Flow (ttm) -30743624 USD

Profile of Verona Pharma

Country United States
State N/A
City London
Address 3 More London Riverside
ZIP SE1 2RE
Phone 44 20 3283 4200
Website https://www.veronapharma.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 35

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.

Q&A For Verona Pharma Stock

What is a current VRNA stock price?

Verona Pharma VRNA stock price today per share is 16.09 USD.

How to purchase Verona Pharma stock?

You can buy VRNA shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Verona Pharma?

The stock symbol or ticker of Verona Pharma is VRNA.

Which industry does the Verona Pharma company belong to?

The Verona Pharma industry is Biotechnology.

How many shares does Verona Pharma have in circulation?

The max supply of Verona Pharma shares is 80.98M.

What is Verona Pharma Price to Earnings Ratio (PE Ratio)?

Verona Pharma PE Ratio is now.

What was Verona Pharma earnings per share over the trailing 12 months (TTM)?

Verona Pharma EPS is -0.72 USD over the trailing 12 months.

Which sector does the Verona Pharma company belong to?

The Verona Pharma sector is Healthcare.

Verona Pharma VRNA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16379.46 USD
-0.12
4.79B USD 16347.38 USD 16420.92 USD 4.79B USD
NASDAQ Global Market Composite NQGM 2283.98 USD
+0.52
2277.12 USD 2296.84 USD
NASDAQ Biotechnology NBI 4429.97 USD
-0.36
4426.59 USD 4461.88 USD
NASDAQ HealthCare IXHC 1011.84 USD
-0.04
1011.35 USD 1017.55 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD